marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Cogent Biosciences Income Statement 2011-2024 | COGT
Annual Income Statement Cogent Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
597 M | 764 M | 230 M | 17.5 M | 22.9 M | 98.6 M | 22.8 M | 22.5 M | - | - | - | - | - |
Shares |
79.7 M | 58.7 M | 38.7 M | 2 M | 7.62 M | 6.22 M | 5.86 M | 5.86 M | - | - | - | - | - |
Historical Prices |
7.5 | 13 | 5.93 | 7.84 | 2.68 | 17 | - | - | - | - | - | - | - |
Net Income |
-192 M | -140 M | -72.3 M | -74.8 M | -31.8 M | -34.5 M | -25.5 M | -18.1 M | -6.59 M | - | - | - | - |
Revenue |
- | - | - | 7.87 M | 22.5 M | 9.73 M | 8.36 M | 6.36 M | 2.99 M | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 7.87 K | - | - | - | - | - | - | - | - | - |
Operating Income |
-208 M | -148 M | -75.6 M | -82.2 M | -32.2 M | -36 M | -26.2 M | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | 78 K | 320 K | 274 K | - | - | - | - | - | - |
EBITDA |
-206 M | -147 M | -75.4 M | -81.5 M | -30.9 M | -34.7 M | -25 M | -18.2 M | -6.41 M | - | - | - | - |
Operating Expenses |
- | - | - | 90.1 M | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
34.4 M | 26.2 M | 19.6 M | 17.4 M | 11 M | 7.45 M | 4.68 M | 3.43 M | 2.73 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Cogent Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
110 M | 99.2 M | 94.8 M | 86.1 M | 86.2 M | 74.8 M | 70.7 M | 69.9 M | 69.6 M | 49.4 M | 45.1 M | 43.8 M | 39.8 M | 38.4 M | 34.9 M | 32.3 M | 9.85 M | 7.78 M | 7.53 M | 30.7 B | 30.7 B | 30.5 B | 30.1 B | 30 B | 29.9 B | 29.2 B | 10.2 B | 10.2 M | 10.2 M | 10.2 M | 10.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-70.6 M | -59 M | -58.3 M | - | -55.4 M | -44.1 M | -38.6 M | - | -35.1 M | -34.9 M | -30.6 M | - | -19.1 M | -16.5 M | -11.7 M | - | -50 M | -7.39 M | -6.09 M | 2.3 M | -11.9 M | -10.5 M | -11.7 M | -8.61 M | -34.5 M | -34.5 M | -34.5 M | -6.69 M | -7 M | -5.86 M | 25.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 312 K | 528 K | 7.03 M | 15.3 M | 1.02 M | 3.14 M | 3.05 M | 3.8 M | 2.04 M | 1.67 M | 2.22 M | 2.12 M | 2.33 M | 2.08 M | 1.83 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-75.4 M | -64.4 M | -62.4 M | - | -59.6 M | -47.1 M | -43.2 M | - | -36.8 M | -35.9 M | -31.4 M | - | -19.8 M | -17.3 M | -12.8 M | - | -57.2 M | -7.4 M | -6.14 M | 2.24 M | -12 M | -10.5 M | -11.8 M | -9 M | -10.6 M | -9.44 M | -6.99 M | -6.88 M | -7.17 M | -6.03 M | -6.07 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
1 K | 44 K | -1 K | - | - | 268 K | 682 K | - | - | - | - | - | - | - | - | - | - | 7 K | - | - | 82 K | - | - | - | 3 K | 157 K | 170 K | - | 70 K | 73 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -61.8 M | - | - | - | -42.7 M | - | -36.4 M | -35.7 M | -31.3 M | - | -19.7 M | -17.3 M | -12.8 M | - | -56.5 M | -6.82 M | -5.85 M | 2.24 M | -11.1 M | -9.88 M | -11.5 M | -9 M | -9.61 M | -8.8 M | -6.67 M | -6.88 M | -6.31 M | -5.47 M | -5.79 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
11.8 M | 10.1 M | 9.7 M | - | 9.45 M | 8.21 M | 7.2 M | - | 6.88 M | 6.38 M | 5.95 M | - | 5.02 M | 4.9 M | 4.59 M | - | 5.6 M | 2.8 M | 3.67 M | - | 2.72 M | 3.06 M | 2.49 M | - | 2.37 M | 1.98 M | 1.06 M | - | 1.32 M | 971 K | 944 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency